Skip to main content

Table 6 The univariate and multivariate analyses predicting IPSS recovery at 12 months after seed implantation

From: Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Univariate

Multiivariate

 

p-value

Odds ratio

p-value

Odds ratio

95% C.I.

Neo-ADT

0.081

0.510

n.s.

  

EBRT

0.036

2.367

n.s.

  

PV at post-dosimetry (mL)

0.066

0.957

n.s.

  

D90(Gy)

0.018

0.984

n.s.

  

UD30(Gy)

0.008

0.986

0.006

0.986

0.957-0.996

  1. Neo ADT: neoadjuvant androgen deprivation therapy, EBRT: external beam radiation therapy, PV: prostate volume, D90: minimal dose (Gy) received by 90% of the prostate gland, UD30: minimal dose (Gy) received by 30% of the urethra.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us